The rounds this investor is named on, who it invests beside, and where it shows up.
Named on 3 rounds in the feed, most often at Series A and in Healthtech.
M13 is a venture capital firm that invests early in visionary founders building through structural shifts that create new markets and opportunities.
Venture capitalNew York, NY, USAm13.coRounds from 2022-11-16 to 2026-09-22
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Baselayer An AI-powered startup that helps financial institutions verify businesses and assess fraud risk | Series A Verified against 1 of 28 sources | $35M | 2026-09-22 | [ LEAD ] |
Ayble Health A clinically-backed digital health platform that provides holistic care for people with GI conditions | Series A Verified against 4 of |
| $16M |
| 2026-09-16 |
| [ PART ] |
Ayble Health A clinically-backed digital health platform that provides holistic care for people with GI conditions | Seed Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $4.6M | 2022-11-16 | [ LEAD ] |